Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2013 3
2014 2
2015 1
2016 3
2017 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.
Vassalli G, Klersy C, De Servi S, Galatius S, Erne P, Eberli F, Rickli H, Hornig B, Bertel O, Bonetti P, Moccetti T, Kaiser C, Pfisterer M, Pedrazzini G; BASKET-PROVE Investigators. Vassalli G, et al. Am Heart J. 2016 Mar;173:1-7. doi: 10.1016/j.ahj.2015.11.007. Epub 2015 Dec 1. Am Heart J. 2016. PMID: 26920590 Clinical Trial.
Long-term outcomes in patients with rheumatologic disorders undergoing percutaneous coronary intervention: a BAsel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination (BASKET-PROVE) sub-study.
Nochioka K, Biering-Sørensen T, Hansen KW, Sørensen R, Pedersen S, Jørgensen PG, Iversen A, Shimokawa H, Jeger R, Kaiser C, Pfisterer M, Galatius S; BASKET-PROVE Investigators. Nochioka K, et al. Eur Heart J Acute Cardiovasc Care. 2017 Dec;6(8):778-786. doi: 10.1177/2048872616649860. Epub 2016 May 10. Eur Heart J Acute Cardiovasc Care. 2017. PMID: 27166320 Clinical Trial.
Improved two-year outcomes after drug-eluting versus bare-metal stent implantation in women and men with large coronary arteries: importance of vessel size.
Hansen KW, Kaiser C, Hvelplund A, Soerensen R, Madsen JK, Jensen JS, Pedersen SH, Eberli FR, Erne P, Alber H, Pfisterer M, Galatius S; BASKET PROVE Investigators. Hansen KW, et al. Int J Cardiol. 2013 Oct 25;169(1):29-34. doi: 10.1016/j.ijcard.2013.08.091. Epub 2013 Sep 8. Int J Cardiol. 2013. PMID: 24063913 Clinical Trial.
Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations.
Jeger RV, Pfisterer ME, Sørensen R, von Felten S, Alber H, Bonetti PO, Eberli F, Erne P, Pedrazzini G, Rickli H, Galatius S, Kaiser CA; BASKET and BASKET-PROVE investigators. Jeger RV, et al. Am Heart J. 2014 Nov;168(5):698-705. doi: 10.1016/j.ahj.2014.07.019. Epub 2014 Jul 30. Am Heart J. 2014. PMID: 25440798 Clinical Trial.
Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design.
Pfisterer M, Bertel O, Bonetti PO, Brunner-La Rocca HP, Eberli FR, Erne P, Galatius S, Hornig B, Kiowski W, Pachinger O, Pedrazzini G, Rickli H, De Servi S, Kaiser C; BASKET-PROVE Investigators. Pfisterer M, et al. Am Heart J. 2008 Apr;155(4):609-14. doi: 10.1016/j.ahj.2007.11.011. Epub 2008 Feb 21. Am Heart J. 2008. PMID: 18371466 Clinical Trial.
Frequency of Cardiac Death and Stent Thrombosis in Patients With Chronic Obstructive Pulmonary Disease Undergoing Percutaneous Coronary Intervention (from the BASKET-PROVE I and II Trials).
Jatene T, Biering-Sørensen T, Nochioka K, Mangione FM, Hansen KW, Sørensen R, Jensen JS, Jørgensen PG, Jeger R, Kaiser C, Pfisterer M, Galatius S; BASKET-PROVE Investigators. Jatene T, et al. Am J Cardiol. 2017 Jan 1;119(1):14-19. doi: 10.1016/j.amjcard.2016.09.013. Epub 2016 Sep 29. Am J Cardiol. 2017. PMID: 27788931 Clinical Trial.
Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trial.
Jensen MT, Kaiser C, Sandsten KE, Alber H, Wanitschek M, Iversen A, Jensen JS, Pedersen S, Soerensen R, Rickli H, Zurek M, Fahrni G, Bertel O, De Servi S, Erne P, Pfisterer M, Galatius S; BASKET-PROVE investigators. Jensen MT, et al. Int J Cardiol. 2013 Oct 9;168(4):3802-6. doi: 10.1016/j.ijcard.2013.06.034. Epub 2013 Jul 11. Int J Cardiol. 2013. PMID: 23849965 Clinical Trial.
Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease.
Wanitschek M, Pfisterer M, Hvelplund A, De Servi S, Bertel O, Jeger R, Rickenbacher P, Iversen A, Jensen JS, Galatius S, Kaiser C, Alber H; BASKET-PROVE Investigators. Wanitschek M, et al. Int J Cardiol. 2013 Oct 3;168(3):2381-8. doi: 10.1016/j.ijcard.2013.01.257. Epub 2013 Feb 27. Int J Cardiol. 2013. PMID: 23453439 Clinical Trial.